“A Randomized Vehicle-Controlled Trial to Assess the Efficacy, Safety, and Tolerability of Ozenoxacin 1% Cream in 412 Patients 2 Months and Older With Impetigo”. 2017. SKIN The Journal of Cutaneous Medicine 1 (3.1): s103. https://doi.org/10.25251/skin.1.supp.102.